In this week's video, Dr. Brian Durie discusses the implications of being MRD-negative if you have high-risk 17p- myeloma.

Bottom Line:

Testing will hopefully lead to improved therapies for patients with 17p- myeloma.

Previous Post
#AskDrDurie: Do bone lesions regenerate?
Next Post
#AskDrDurie: Can you help make sense of statistics?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.